title: Colesevelam as an Add-On Treatment for Control of Dyslipidemia and Hyperglycemia in Type 2 Diabetes.
authors.affiliation: Division of Endocrinology and Metabolism, Healthy Heart Program Prevention Clinic and Centre for Heart Lung Innovation, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada.
authors.forename: Supna
authors.initials: S
authors.lastname: Sandhu
authors.affiliation: Division of Endocrinology and Metabolism, Healthy Heart Program Prevention Clinic and Centre for Heart Lung Innovation, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada.
authors.forename: Mandana
authors.initials: M
authors.lastname: Moosavi
authors.affiliation: Division of Endocrinology and Metabolism, Healthy Heart Program Prevention Clinic and Centre for Heart Lung Innovation, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada.
authors.forename: Kamran
authors.initials: K
authors.lastname: Golmohammadi
authors.affiliation: Division of Endocrinology and Metabolism, Healthy Heart Program Prevention Clinic and Centre for Heart Lung Innovation, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada. Electronic address: gordon.francis@hli.ubc.ca.
authors.forename: Gordon A
authors.initials: GA
authors.lastname: Francis
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069472:Colesevelam Hydrochloride / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D050171:Dyslipidemias / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*
chemical_list: D000924:Anticholesteremic Agents; D000069472:Colesevelam Hydrochloride